Statistics for Aurinia Pharmaceuticals Inc (id:6450 AUPH)
Valuation metrics
Market cap
1.29B
Enterprise value
1.03B
Trailing P/E (ttm)
-16.63
Forward P/E
16.72
PEG ratio
16.72
Price/Sales (ttm)
5.87
Price/Book (mrq)
3.33
Enterprise Value/Revenue
4.69
Enterprise Value/EBITDA
2.09K
Overview
Shares outstanding
143.18M
Float
128.87M
Shares short
6.22M
% Held by insiders
5.00%
% Held by institutions
3.00%
Average volume (10 days)
1.75M
Average volume (90 days)
Price summary
52-Week low
4.71
52-Week high
10.67
52-Week change
-3.45%
Beta
1.46
50-Day moving average
8.24
200-Day moving average
6.37
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
October 23, 2013
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-10.23%
Operating margin
17.33%
Operational effectiveness
Return on assets
-2.16%
Return on equity
-5.78%
Income statement
Revenue (ttm)
1.54
Revenue per share (ttm)
1.54
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
161.36M
EBITDA
495.00K
Net income to common (ttm)
-22,552,000.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
24.32%
Balance sheet
Total cash (mrq)
348.24M
Total cash per share (mrq)
2.43
Total debt (mrq)
87.85M
Total Debt/Equity (mrq)
22.64
Current ratio (mrq)
560.30%
Book value per share (mrq)
2.71
Cash flow
Cash flow statement
28.59M
Levered free cash flow (LFCF)
38.91M